Lexington, MA, United States of America

Banumathi Sankaran

This inventor holds 39 USPTO granted patents and 7 published patent applications, plus 13 CIPO patents and 26 EPO patents, primarily in Therapeutic Antibodies. Top assignees: Janssen Pharmaceutica Nv, Ortho-Clinical Diagnostics, Inc, Saladax Biomedical Inc.. Active years: 2013-2022.

USPTO Granted Patents = 39 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 7.4

ph-index = 14

Forward Citations = 255(Granted Patents)


Location History:

  • Pittsford, NY (US) (2013 - 2022)
  • Lexington, MA (US) (2017 - 2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Therapeutic Antibodies
Paliperidone
Olanzapine
Aripiprazole
Quetiapine
Risperidone
Haptens
Immunoassays
sFlt-1
Glycosaminoglycans
Non-Specific Binding
Angiogenic Factor Complex
39 patents (USPTO):Explore Patents

Title: Inventor Banumathi Sankaran - Pioneering Innovations in Lexington

Introduction: Banumathi Sankaran is a distinguished inventor based in Lexington, MA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Banumathi Sankaran holds several patents in the areas of artificial intelligence, machine learning, and data analytics, showcasing her expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Banumathi Sankaran has worked with leading tech companies, research institutions, and universities, driving forward the boundaries of technological advancements.

Collaborations: Throughout her career, Banumathi Sankaran has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and knowledge-sharing in the tech industry.

Conclusion: Banumathi Sankaran's passion for innovation and her relentless pursuit of technological excellence continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…